Neither has gone through Phase 3 clinical trials for musculoskeletal indications
Understanding the transition between different GLP-1 agonists is also relevant for long-term planning
And, depending on your health and family history they may not be appropriate for you
It is important to note that while these medications can be taken long-term, there is no official requirement to take them "forever." Treatment duration should be determined collaboratively between patient and physician based on individual circumstances, treatment response, and evolving health needs
contact your trial team or NHS 111 promptly for persistent vomiting, dehydration, hypoglycaemia symptoms, or significant mood changes
Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon Limited, Boehringer Ingelheim International GmbH, Amgen Inc., AstraZeneca PLC, Roche Holding AG, Zealand Pharma A/S, Hanmi Pharmaceutical Co., Ltd., Structure Therapeutics Inc., Altimmune, Inc., United Laboratories International Holdings Limited, Entera Bio Ltd., OPKO Health, Inc., Viking Therapeutics, Inc., Twist Bioscience Corporation and others GLP-1 agonists market is segmented based on Product, Indication , Route of Administration, Distribution Channel and Region
